Drug Product Development for the Back of the Eye

Editors:

ISBN: 978-1-4419-9919-1 (Print) 978-1-4419-9920-7 (Online)

Table of contents (22 chapters)

previous Page of 2
  1. Front Matter

    Pages i-xii

  2. No Access

    Book Chapter

    Pages 1-20

    Selection of Drug Delivery Approaches for the Back of the Eye: Opportunities and Unmet Needs

  3. No Access

    Book Chapter

    Pages 21-45

    Microdialysis for Vitreal Pharmacokinetics

  4. No Access

    Book Chapter

    Pages 47-84

    Fluorophotometry for Pharmacokinetic Assessment

  5. No Access

    Book Chapter

    Pages 85-109

    Systemic Route for Retinal Drug Delivery: Role of the Blood-Retinal Barrier

  6. No Access

    Book Chapter

    Pages 111-124

    Topical Drug Delivery to the Back of the Eye

  7. No Access

    Book Chapter

    Pages 125-158

    Principles of Retinal Drug Delivery from Within the Vitreous

  8. No Access

    Book Chapter

    Pages 159-171

    Transscleral Drug Delivery

  9. No Access

    Book Chapter

    Pages 173-184

    Suprachoroidal and Intrascleral Drug Delivery

  10. No Access

    Book Chapter

    Pages 185-230

    Advances in Biodegradable Ocular Drug Delivery Systems

  11. No Access

    Book Chapter

    Pages 231-259

    Microparticles as Drug Delivery Systems for the Back of the Eye

  12. No Access

    Book Chapter

    Pages 261-290

    Nanotechnology and Nanoparticles

  13. No Access

    Book Chapter

    Pages 291-304

    Hydrogels for Ocular Posterior Segment Drug Delivery

  14. No Access

    Book Chapter

    Pages 305-329

    Refillable Devices for Therapy of Ophthalmic Diseases

  15. No Access

    Book Chapter

    Pages 331-360

    Targeted Drug Delivery to the Eye Enabled by Microneedles

  16. No Access

    Book Chapter

    Pages 361-390

    Ocular Iontophoresis

  17. No Access

    Book Chapter

    Pages 391-408

    Drug and Gene Therapy Mediated by Physical Methods

  18. No Access

    Book Chapter

    Pages 409-448

    Protein Drug Delivery and Formulation Development

  19. No Access

    Book Chapter

    Pages 449-468

    Drug Suspension Development for the Back of the Eye

  20. No Access

    Book Chapter

    Pages 469-484

    Regulatory Considerations in Product Development for Back of the Eye

  21. No Access

    Book Chapter

    Pages 485-493

    Clinical Endpoints for Back of the Eye Diseases

previous Page of 2